| 國立成功大學 |
2022 |
Clinical characteristics and outcomes of drug-induced liver injury in Taiwan: With emphasis on the impact of chronic hepatitis B infection
|
Huang, Y.-S.;Tseng, S.-Y.;Chen, W.-W.;Chang, T.-T.;Peng, C.-Y.;Lo, G.-H.;Hsu, C.-W.;Hu, C.-T.;Huang, Y.-H. |
| 國立成功大學 |
2022 |
Deletion of MicroRNA-21 Impairs Neovascularization Following Limb Ischemia: From Bedside to Bench
|
Chang, W.-T.;Lin, Y.-W.;Huang, P.-S.;Lin, Y.-C.;Tseng, S.-Y.;Chao, T.-H.;Chen, Z.-C.;Shih, J.-Y.;Hong, C.-S. |
| 國立成功大學 |
2022 |
Compact and Robust Bent Axis Waveguide Coupler with a Sign Flip of the Phase Mismatch
|
Wu, B.-T.;Tseng, S.-Y. |
| 國立成功大學 |
2022 |
Ultra-broadband Silicon Polarization Independent 3-dB Coupler using Multi-parameter Adiabaticity Engineering
|
Chung, H.-C.;Tseng, S.-Y. |
| 臺大學術典藏 |
2021-08-05T02:42:28Z |
Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hyperthermia combined with chemotherapy
|
Yang S.-J;Tseng S.-Y;Wang C.-H;Young T.-H;Chen K.-C;Shieh M.-J.; Yang S.-J; Tseng S.-Y; Wang C.-H; Young T.-H; Chen K.-C; Shieh M.-J.; MING-JIUM SHIEH |
| 臺大學術典藏 |
2021-08-05T02:42:03Z |
Magnetic nanomedicine for CD133-expressing cancer therapy using locoregional hyperthermia combined with chemotherapy
|
Yang S.-J;Tseng S.-Y;Wang C.-H;Young T.-H;Chen K.-C;Shieh M.-J.; Yang S.-J; Tseng S.-Y; Wang C.-H; Young T.-H; Chen K.-C; Shieh M.-J.; TAI-HORNG YOUNG |
| 臺大學術典藏 |
2021-02-04T02:30:54Z |
Magnetite-based nanomedicine for cancer diagnosis and therapy using loco-regional hyperthermia combined with chemotherapy
|
Yang, S.-J.;Tseng, S.-Y.;Wang, C.-H.;Young, T.-H.;Shieh, M.-J.; Yang, S.-J.; Tseng, S.-Y.; Wang, C.-H.; Young, T.-H.; Shieh, M.-J.; MING-JIUM SHIEH; TAI-HORNG YOUNG |
| 國立成功大學 |
2021 |
Ultra-Broadband Silicon Polarization Splitter-Rotator using Adiabaticity Engineering
|
Chung, H.-C.;Lu, G.-X.;Tseng, S.-Y. |
| 臺大學術典藏 |
2020-12-28T12:03:53Z |
Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: Study protocol for a multi-center randomized controlled trial
|
Tsai L.-M.; HWANG, JUEY-JEN; Tseng S.-Y.; Li Y.-H.; Lee P.-T.; Lee W.-H.; Hsu P.-C.; Lin C.-C.; Chu C.-Y.; Chao T.-K.; Liu P.-Y.; Chen I.-C.; Lee C.-H.; Chao T.-H.; Tseng W.-K.; Lin T.-H.; Chung W.-J.; Li J.-K.; Huang H.-L. |
| 臺大學術典藏 |
2020-12-28T02:40:18Z |
Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells
|
YEN-HUI CHEN; Tseng S.-Y.; Chen T.-M.; Yu S.-T.; Yu S.-T.;Chen T.-M.;Tseng S.-Y.;Yen-Hui Chen |
